Kashyap Thummar

Dr. Kashyap Thummar

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2024 in Steroids
Verified
Journal Article
Closed access
FRForam K. Ravat
Foram K. Ravat
JGJanki R. Goswami
Janki R. Goswami
SNSneha M. Nair
Sneha M. Nair
Kashyap ThummarKashyap Thummar
Kashyap Thummar

11 November 2024 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
Kashyap ThummarKashyap Thummar
Kashyap Thummar
KHKevat Honey
Kevat Honey
VPVadher Priyanka
Vadher Priyanka
JMJesur Mihir
Jesur Mihir
Background: Diabetes mellitus affects millions globally, necessitating effective management strategies. Glenmark Pharmaceutical Limited introduced a fixed-dose combination of teneligliptin and dapagliflozin in 2022 to address this need. However, existing methods for their simultaneous detection are limited, lacking forced degradation studies essential for assessing drug stability. Results: A stability-indicating RP-HPLC method was developed for the simultaneous determination of dapagliflozin and teneligliptin in pharmaceutical formulations. The separation was efficiently achieved employing a Zorbax Eclipse Plus C18 column (150 mm × 4.6 mm, 5 µm). The mobile phase comprised a mixture of 10 mM ammonium acetate buffer in water, methanol, and acetonitrile in a suitable proportion and delivered at a flow rate of 0.6 mL/min. Detection of the isocratic eluents was performed at 224 nm using a photodiode array (PDA) detector. Validation against various stress conditions, as per ICH guidelines, revealed significant degradation of teneligliptin primarily under acidic, basic, and oxidative stress. Moreover, liquid chromatography tandem mass spectrometry (LC-MS/MS)-based characterization was conducted for the primary degradation products of teneligliptin generated under acidic, basic, and oxidative conditions. Conclusions: The developed RP-HPLC method with a stability-indicating approach provides an efficient means for the simultaneous determination of dapagliflozin and teneligliptin in pharmaceutical formulations. The significant degradation was observed under various stress conditions and also successfully separated the degradation products by this method. The proposed method directly applied for the characterization of degradation products and based on LC-MS/MS data the structure of degradation products was generated and also degradation pathways under various stress conditions were predicted. The proposed method ensured accurate and precise results in quality control process in pharmaceutical industry, and adherence to ICH validation guidelines affirms its reliability in assessing the stability of these compounds.

28 August 2020 in JPC – Journal of Planar Chromatography – Modern TLC
Verified
Journal Article
Closed access
PDF file
Kashyap ThummarKashyap Thummar
Kashyap Thummar
KTKevin Tilva
Kevin Tilva
BDBhumika Dudhatra
Bhumika Dudhatra
RMRajnikant Mardia
Rajnikant Mardia
NSNavin Sheth
Navin Sheth

1 January 2015 in Scientia Pharmaceutica
Verified
Journal Article
Open access
Kashyap ThummarKashyap Thummar
Kashyap Thummar
DGDilip J Ghava
Dilip J Ghava
AMAnvi Mistry
Anvi Mistry
AVAshish Vachhani
Ashish Vachhani
NSNavin R Sheth
Navin R Sheth
A novel, stability-indicating high-performance liquid chromatographic (HPLC) method is delivered for the determination of fluphenazine hydrochloride (FPZ) and its degradation products. The forced degradation testing of FPZ was carried out for hydrolytic, oxidative, photolytic, and thermal degradation. The degradation appeared using a reversed-phase C18 column at ambient temperature with a mobile phase comprised of methanol : acetonitrile : (10 mM) ammonium acetate (70:15:15, v/v/v) pH 6.0, adjusted with acetic acid, having a flow rate of 1 ml min(-1) and a detection wavelength at 259 nm. Primarily, the maximum degradation products were formed under oxidative stress conditions. The product was distinguished through LC-MS/MS fragmentation studies. Based on the results, a more complete degradation pathway for the drug could be proposed. The modernized method was found to be precise, accurate, specific, and selective. The method was found to be suitable for the quality control of fluphenazine hydrochloride in the tablet as well as in stability-indicating studies.


30 July 2022 in International Journal of Pharmaceutical Sciences and Drug Research
Verified
Journal Article
Open access
PDF file
Kashyap ThummarKashyap Thummar
Kashyap Thummar
MPMalay Pandya
Malay Pandya
NPNisarg Patel
Nisarg Patel
FRForam Rawat
Foram Rawat
SCSanjay Chauhan
Sanjay Chauhan
A simple and rapid UV spectrophotometric method was developed for quantification of remdesivir in bulk and its dosage form which was used in the treatment of COVID 19. Analytical Quality by Design (AQbD) approach was implemented for method development and the relationship between variable input parameters and the method performance characteristics were designed into Ishikawa diagram. The critical parameters were optimized for solvent, wavelength, scan speed and sampling interval, determined by using principal component analysis as well as by observation. The present method was validated according to ICH Q2 (R1) guideline. The method was found excellent linear (r2 ≥ 0.999) at concentration range of 2 -12 μg/mL at maximum wavelength of 245.5 nm. The detection limit and quantitation limit were satisfactorily found to sensitive and precise. The intraday and interday precision were achieved consistent and percentage relative standard deviation (% RSD) were found ≤ 2%. The overall results of forced degradation studies such as acidic, basic, oxidative, thermal and photolytic conditions imply that the developed method could be well implemented as a stability indicating method for the estimation of remdesivir. The result confirmed that the method can be useful for the routine quality control of remdesivir in their pharmaceutical formulations.